Aquestive Therapeutics, Inc. (AQST) › Capital ExpendituresAquestive Therapeutics, Inc. (AQST) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2017: $2.07M2018: $1.82M2019: $663.0K2020: $517.0K2021: $913.0K2022: $1.02M2023: $995.0K2024: $159.0K2025: $562.0K$562.0K2017Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$562.0K+253.5%2024$159.0K-84.0%2023$995.0K-2.8%2022$1.02M+12.2%2021$913.0K+76.6%2020$517.0K-22.0%2019$663.0K-63.7%2018$1.82M-11.8%2017$2.07M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share